IMPORTANT UPDATES

To submit a grant request you must first be registered in the Request Management System (RMS).

Using Google Chrome or Firefox, go here to register:  https://webportalapp.com/sp/login/teva-registration.

Once your registration is approved, you will receive an email from the RMS with the submission link (https://webportalapp.com/sp/login/teva-grantrequest) and you will be able to submit a request.

 

For refund checks, please note the new address to submit:Teva Pharmaceuticals, Attention: Medical Education Department, 400 Interpace Parkway, #3, Parsippany, NJ 07054

 

For any inquiries email: tevarequestmanagement@tevapharm.com or call 800-961-3604. Please include the grant number if applicable.

 

important

Education Objectives: Migraine

Migraine - HCP
• Support education to improve HCP knowledge and competence in migraine management including but not limited to Calcitonin Gene-Related Peptide (CGRP), up-to-date data, HCP experience, appropriate patient selection for preventative treatments, concomitant therapies, and co-morbidities.

 

• Support education to improve HCP knowledge and competence in managing the disease of migraine, in understanding its symptoms and clinical features, and of diagnosing episodic and chronic migraine.

 

• Support education and scientific exchange regarding issues of persistence and adherence to migraine medications

 

• Support education to improve HCP awareness and knowledge of the socioeconomic burden of migraine

 

• Support education to facilitate team-based learning and communication among all clinicians involved with the care of patients suffering with migraine

 

• Support educational programs that facilitate the continuing professional development of medical students or residents


Migraine Audience Groups: Neurologists/ Headache Specialists, Nurse Practitioners, Physician Assistants, Primary Care Physician, Pain Specialists, Psychiatrists, Nurses, Pharmacists, medical students, residents

Education Objectives: Huntington's Disease

Huntington’s Disease - HCP
• Support education to improve HCP knowledge and competence in diagnosing Huntington’s Disease, including understanding genetic factors, disease state pathophysiology, and the triad of symptoms that may impact quality of life

 

• Support education to improve HCP understanding of the disease burden and improve competence in understanding the complete clinical profile of current and potential treatment options for Huntington’s Disease

 

• Support education to improve HCP knowledge and competence in managing Huntington’s Disease-related chorea, including identifying the appropriate treatment and ensuring access as well as understanding the importance of adherence and persistence

 

HD Audience Groups: Neurologists, Psychiatrists, Nurses, Nurse Practitioners, Physician Assistants, and Pharmacists

Education Objectives: Tardive Dyskinesia

Tardive Dyskinesia - HCP
• Support education to improve HCP knowledge and competence in diagnosing Tardive Dyskinesia, including understanding disease state pathophysiology, symptom recognition, conditions and medications known to be associated with Tardive Dyskinesia, and differential diagnosis of hyperkinetic movement disorders

 

• Support education to improve HCP knowledge of the clinical efficacy and safety profile of current and potential treatment options for Tardive Dyskinesia and of the importance of early treatment and impact (social, economic, physical, functioning) of untreated TD

 

• Support education to increase HCP confidence and competence in treating Tardive Dyskinesia including monitoring, assessing with AIMS, managing medication adherence, and improving clinical experience on long term treatment; this also includes treating via telemedicine

 

• Support education to increase HCP confidence and competence in addressing barriers to long-term treatment success with VMAT2 inhibitors, in concomitant use of VMAT2 inhibitors and antipsychotic treatment, and in appropriate titration and maintenance for optimal VMAT2 inhibitor efficacy, safety & medication adherence


TD Audience Groups: Psychiatrists, Neurologists, Nurses, Nurse Practitioners, Physician Assistants, and Pharmacists

Education Objectives: Asthma

We are not currently supporting any grants for asthma or Respiratory

Education Objectives: Schizophrenia

Schizophrenia – HCP
• Support education to improve knowledge of schizophrenia including disease progression and burden of disease


• Support education to increase awareness and understanding of the clinical efficacy and safety profile of current and emerging schizophrenia treatment options including those with different routes of administration


• Support education to increase competence in optimizing the treatment of schizophrenia including starting treatment, patient monitoring, defining patient success, and switching treatments


• Support education to increase awareness of the short and long term benefits of early and continuous intervention


Schizophrenia Audience Groups: Psychiatrists, Psychiatric NPs, Psychiatric PAs, Psychiatric Nurses, Psychiatric Pharmacists